Prostate Cancer Clinical Trials in Portland

Showing 121-140 of 200 trials

Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation Therapy

NCT03135782

This pilot clinical trial studies how well provider training works in increasing patient tobacco cessation counseling and referrals for patients with cancer undergoing radiation therapy. Health care provider training in motivational interviewing techniques and utilizing tobacco cessation resources may help doctors understand how health care providers can effectively increase their confidence in talking to patients about tobacco cessation counseling.

Breast CarcinomaCaregiverHead and Neck Carcinoma+3 more

OHSU Knight Cancer Institute2 participantsStarted Aug 2017

Portland, Oregon, United States

COMPLETEDPhase 2< 1 mile

Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer

NCT00411528

The objective of this study is to assess the response of patupilone plus prednisone compared to docetaxel plus prednisone on prostate specific antigen (PSA) in patients with metastatic hormone refractory prostate cancer. Additionally, this study will assess the response on measureable disease and the effects on patient-reported outcomes.

Metastatic Hormone Refractory Prostate Cancer

Novartis Pharmaceuticals185 participantsStarted Sep 2006

La Jolla, California, United States • Aurora, Colorado, United States • Norwalk, Connecticut, United States +29 more locations

Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation Therapy

Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer

Prostate Cancer Trials in Other Cities

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors

Exercising Together During Radiation Treatment

Prostate Cancer Intervention Versus Observation Trial (PIVOT)

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC)

Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer

Docetaxel and Carboplatin for Patients With mCRPC and DNA-Repair Deficiencies

Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer

A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSF

Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer

ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer

Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer

Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer

GTI-2040, Docetaxel, and Prednisone in Treating Patients With Prostate Cancer

Biomarkers of Androgen Response and Resistance In Evolution During a Rising PSA

Firmagon (Degarelix) Intermittent Therapy

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

Other Conditions in Portland